跳至主要内容
临床试验/NCT01115101
NCT01115101已完成4 期

A Randomized Controlled Trial: Pain Management After Cesarean Section: Oxycodon vs. Intravenous Piritramide

Max Dieterich1 个研究点 分布在 1 个国家目标入组 239 人开始时间: 2009年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
239
试验地点
1
主要终点
Difference of Pain Scores on the Visual Analog Scale

研究概览

简要总结

The purpose of this study is to investigate adequate pain treatment for patients after cesarean. In this study oral opioids were compared to intravenous opioids as they are supposed to provide superior pain control.

详细描述

Pain management after cesarean is an important topic for women. Pain during and after surgery is their greatest concern.

After surgery quick mobilization is important to take care of the newborn. When using a patient controlled analgesia (PCA) device mobilization is limited and women can not meet their expectations to take care of the newborn. Oral analgesia in comparison offers superior patient satisfaction.

This trial was conducted to investigate the effectiveness of both treatment options and improve patients pain management and overall content after cesarean.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • cesarean in spinal anesthesia,
  • no history of opioid or metamizol treatment
  • written consent
  • ability to use a Patient-controlled analgesia device

排除标准

  • cesarean in general anaesthesia
  • use of peridural catheter for pre-, peri- or post cesarean analgesia
  • additional post cesarean metamizol use
  • allergy/hypersensitivity to morphine, oxycodon, acetaminophen or ibuprofen
  • chronic use of general anaesthesia
  • history of known pain syndrome

研究组 & 干预措施

Oxycodon

Experimental

干预措施: Oral Oxycodon (Drug)

Patient controlled analgesia (PCA) device with Pritramid

Active Comparator

干预措施: Piritramid (Drug)

结局指标

主要结局

Difference of Pain Scores on the Visual Analog Scale

时间窗: Pain level was evaluated before therapy (2h after CS), 12h, 24h, 32h, 40h, 48 and 72h after CS.

The primary outcome measure was the change in patients assessment of pain after cesarean (CS) from baseline. For pain assessment a visual analog scale (VAS) was used. Women were asked to quantify pain using an eleven point numerical rating score from 0 to 10, with 0 indicating no pain, and 10 the worst pain. Single value were calculated (averaged).

次要结局

  • Mobilisation(6 month)
  • Subgroups(6 month)
  • Side Effects(6 month)
  • Costs(6 month)

研究者

发起方
Max Dieterich
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Max Dieterich

Dr. Max Dieterich

University of Rostock

研究点 (1)

Loading locations...

相似试验

Superiority Study for Pain Treatment After Cesarean | 临床试验